Blood Lead Exposure and Association With Hepatitis B Core Antibody in the United States: NHANES 2011-2018.
NHANES
cross sectional survey
hepatitis B core antibody
metals
serum lead
Journal
Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579
Informations de publication
Date de publication:
2022
2022
Historique:
received:
14
02
2022
accepted:
04
05
2022
entrez:
1
7
2022
pubmed:
2
7
2022
medline:
6
7
2022
Statut:
epublish
Résumé
The objective of this project was to explore the distribution and related factors of blood lead and the association between blood lead and hepatitis B core antibody (HBcAb). All the data were from the U.S. National Health and Nutrition Examination Survey (NHANES). In total, 15,097 (aged 20-80 years) participants were included. Participants without a history of blood transfusion were more likely to be exposed to lower levels of blood lead [-2.30 (-3.13, -1.47) for HBcAb (-) and -2.23 (-4.54, 0.08) for HBcAb (+)]. The odds ratio (
Identifiants
pubmed: 35774563
doi: 10.3389/fpubh.2022.873741
pmc: PMC9239404
doi:
Substances chimiques
Lead
2P299V784P
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
873741Informations de copyright
Copyright © 2022 Han, He, Huang, Sun and Gao.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Eur Rev Med Pharmacol Sci. 2018 Sep;22(18):5906-5913
pubmed: 30280771
Int J Obes (Lond). 2007 May;31(5):871-5
pubmed: 17047638
J Hazard Mater. 2015 Nov 15;298:122-8
pubmed: 26022852
Environ Res. 2018 Oct;166:570-576
pubmed: 29966877
J Blood Med. 2022 Mar 03;13:113-119
pubmed: 35264893
Emerg Med J. 2003 Jan;20(1):54-60
pubmed: 12533370
Environ Int. 2019 Nov;132:105115
pubmed: 31473411
Environ Sci Pollut Res Int. 2016 May;23(9):8244-59
pubmed: 26965280
Environ Int. 2019 Dec;133(Pt B):105192
pubmed: 31639605
J Diabetes Investig. 2022 Mar 27;:
pubmed: 35340117
J Am Heart Assoc. 2020 Jul 7;9(13):e015533
pubmed: 32573312
Int J Environ Res Public Health. 2010 Sep;7(9):3332-47
pubmed: 20948927
Toxicol Appl Pharmacol. 2020 Mar 15;391:114901
pubmed: 32004562
Prev Chronic Dis. 2013 Dec 19;10:E213
pubmed: 24355106
J Clin Virol. 2003 Jul;27(2):162-9
pubmed: 12829038
Am J Prev Med. 2021 Apr;60(4):e179-e187
pubmed: 33485723
JAMA. 1994 Jul 27;272(4):277-83
pubmed: 8028140
Environ Int. 2018 Dec;121(Pt 1):683-694
pubmed: 30316184
Environ Res. 2015 Oct;142:273-80
pubmed: 26186135
J Toxicol Environ Health A. 2022 May 3;85(9):376-380
pubmed: 35000561
J Viral Hepat. 2020 Nov;27(11):1108-1118
pubmed: 32506771
Environ Health Perspect. 1998 Nov;106(11):745-50
pubmed: 9799191
J Acquir Immune Defic Syndr. 2010 Jun;54(2):122-8
pubmed: 20386111
Ann Glob Health. 2019 Apr 11;85(1):
pubmed: 30977623
Sci Total Environ. 2020 Jul 15;726:138446
pubmed: 32320874
Toxicol Ind Health. 2022 Mar;38(3):139-150
pubmed: 35230206
JAMA. 1994 Jul 27;272(4):284-91
pubmed: 8028141
Environ Pollut. 2020 Jun;261:114093
pubmed: 32062095
Environ Res. 2018 May;163:194-200
pubmed: 29454851
Am J Med. 2016 Nov;129(11):1213-1218
pubmed: 27341956
Int J Environ Res Public Health. 2020 Mar 10;17(5):
pubmed: 32164251
Psychiatriki. 2016 Jul-Sep;27(3):204-214
pubmed: 27837574
Pharmacotherapy. 2019 Dec;39(12):1190-1203
pubmed: 31596963
Euroasian J Hepatogastroenterol. 2016 Jul-Dec;6(2):163-166
pubmed: 29201750
Lancet Glob Health. 2016 Aug;4(8):e568-78
pubmed: 27443782
Adv Biomed Res. 2015 Jan 30;4:17
pubmed: 25709982
Am J Gastroenterol. 2017 Dec;112(12):1780-1788
pubmed: 29087395
Postgrad Med J. 2017 Sep;93(1103):513-518
pubmed: 27555608
Chemosphere. 2022 May;294:133656
pubmed: 35051511
Korean J Pediatr. 2019 Nov;62(11):416-421
pubmed: 31401825